CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 80 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -42.9% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | -12.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | -76.5% | 10,000 | -66.7% | 0.00% | -75.0% |
| Q4 2021 | $34,000 | -54.7% | 30,000 | 0.0% | 0.00% | -55.6% |
| Q3 2021 | $75,000 | -15.7% | 30,000 | 0.0% | 0.01% | -18.2% |
| Q2 2021 | $89,000 | -15.2% | 30,000 | 0.0% | 0.01% | -21.4% |
| Q1 2021 | $105,000 | +10.5% | 30,000 | +50.0% | 0.01% | -6.7% |
| Q4 2020 | $95,000 | -2.1% | 20,000 | 0.0% | 0.02% | -11.8% |
| Q3 2020 | $97,000 | +49.2% | 20,000 | 0.0% | 0.02% | +41.7% |
| Q2 2020 | $65,000 | -36.3% | 20,000 | 0.0% | 0.01% | -42.9% |
| Q1 2020 | $102,000 | +12.1% | 20,000 | 0.0% | 0.02% | +90.9% |
| Q4 2019 | $91,000 | -25.4% | 20,000 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $122,000 | 0.0% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $122,000 | +9.9% | 20,000 | 0.0% | 0.01% | +18.2% |
| Q1 2019 | $111,000 | -1.8% | 20,000 | 0.0% | 0.01% | -15.4% |
| Q4 2018 | $113,000 | -46.2% | 20,000 | 0.0% | 0.01% | -27.8% |
| Q3 2018 | $210,000 | -5.4% | 20,000 | 0.0% | 0.02% | -5.3% |
| Q2 2018 | $222,000 | +38.8% | 20,000 | 0.0% | 0.02% | +35.7% |
| Q1 2018 | $160,000 | -2.4% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $164,000 | – | 20,000 | 0.0% | 0.01% | – |
| Q3 2017 | $0 | -100.0% | 20,000 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $121,000 | +14.2% | 20,000 | 0.0% | 0.01% | +10.0% |
| Q1 2017 | $106,000 | -22.1% | 20,000 | 0.0% | 0.01% | +11.1% |
| Q4 2016 | $136,000 | -13.4% | 20,000 | -5.7% | 0.01% | -18.2% |
| Q3 2016 | $157,000 | -9.8% | 21,200 | 0.0% | 0.01% | -15.4% |
| Q2 2016 | $174,000 | +37.0% | 21,200 | 0.0% | 0.01% | +30.0% |
| Q1 2016 | $127,000 | +12.4% | 21,200 | 0.0% | 0.01% | +11.1% |
| Q4 2015 | $113,000 | +32.9% | 21,200 | 0.0% | 0.01% | +28.6% |
| Q3 2015 | $85,000 | -18.3% | 21,200 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $104,000 | +25.3% | 21,200 | 0.0% | 0.01% | +14.3% |
| Q4 2014 | $83,000 | +5.1% | 21,200 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $79,000 | +8.2% | 21,200 | 0.0% | 0.01% | +16.7% |
| Q2 2014 | $73,000 | 0.0% | 21,200 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $73,000 | -50.7% | 21,200 | -50.0% | 0.01% | 0.0% |
| Q4 2013 | $148,000 | +92.2% | 42,400 | +100.0% | 0.01% | 0.0% |
| Q3 2013 | $77,000 | -27.4% | 21,200 | 0.0% | 0.01% | -36.4% |
| Q2 2013 | $106,000 | – | 21,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |